Sacituzumab Govitecan-hziy

Sacituzumab Govitecan-hziy · Targeted Antibody-Drug Conjugate (ADC)

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

Metastatic Triple-Negative Breast Cancer (TNBC), HR+/HER2- Breast Cancer, and locally advanced or metastatic Urothelial Carcinoma.

Contraindications

Hypersensitivity to active ingredient or any formulation excipients.

Side Effects & Warnings

Severe diarrhea, severe neutropenia, nausea, vomiting, alopecia, fatigue.

Drug & Dietary Interactions

Caution with strong CYP3A inhibitors or inducers; review concurrent medications.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.